150 related articles for article (PubMed ID: 33902413)
41. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma.
Holland HK; Saral R; Rossi JJ; Donnenberg AD; Burns WH; Beschorner WE; Farzadegan H; Jones RJ; Quinnan GV; Vogelsang GB
Ann Intern Med; 1989 Dec; 111(12):973-81. PubMed ID: 2512828
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of rifabutin during atazanavir/ritonavir co-administration in HIV-infected TB patients.
Ramachandran G; Hemanth Kumar AK; Kannan T; Sridhar R; Guha SK; Kadam D; Poorana Gangadevi N; Rajapandian T
Indian J Tuberc; 2019 Jan; 66(1):129-133. PubMed ID: 30797270
[TBL] [Abstract][Full Text] [Related]
43. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.
Swindells S; DiRienzo AG; Wilkin T; Fletcher CV; Margolis DM; Thal GD; Godfrey C; Bastow B; Ray MG; Wang H; Coombs RW; McKinnon J; Mellors JW;
JAMA; 2006 Aug; 296(7):806-14. PubMed ID: 16905786
[TBL] [Abstract][Full Text] [Related]
44. Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV.
Li M; Chan WW; Zucker SD
J Am Heart Assoc; 2020 Oct; 9(19):e016310. PubMed ID: 32930032
[TBL] [Abstract][Full Text] [Related]
45. HIV/SARS-CoV-2 coinfection: A global perspective.
Kanwugu ON; Adadi P
J Med Virol; 2021 Feb; 93(2):726-732. PubMed ID: 32692406
[TBL] [Abstract][Full Text] [Related]
46. Tocilizumab in HIV patient with severe COVID-19: case report.
Bertozzi PV; de Oliveira Vicente A; Pereira AS; de Sant'Ana JPE; Mano RBC; Jorge LS; da Silva Sardenberg RA
AIDS Res Ther; 2021 Oct; 18(1):73. PubMed ID: 34656134
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
Sevinsky H; Zaru L; Wang R; Xu X; Pikora C; Correll TA; Eley T
Pediatr Infect Dis J; 2018 Jun; 37(6):e157-e165. PubMed ID: 29206748
[TBL] [Abstract][Full Text] [Related]
48. COVID-19 pneumonia in an HIV-positive woman on antiretroviral therapy and undetectable viral load in Porto Alegre, Brazil.
Cipolat MM; Sprinz E
Braz J Infect Dis; 2020; 24(5):455-457. PubMed ID: 32866436
[TBL] [Abstract][Full Text] [Related]
49. Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.
Ferretti F; Bigoloni A; Passeri L; Galli L; Longo V; Gerevini S; Spagnuolo V; Gisslen M; Zetterberg H; Fuchs D; Cattaneo D; Caramatti G; Lazzarin A; Cinque P; Castagna A
Medicine (Baltimore); 2016 Jul; 95(28):e4144. PubMed ID: 27428202
[TBL] [Abstract][Full Text] [Related]
50. Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study.
Rosenblatt L; Farr AM; Nkhoma ET; Nelson JK; Ritchings C; Johnston SS
BMC Infect Dis; 2016 Sep; 16():492. PubMed ID: 27643691
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
[TBL] [Abstract][Full Text] [Related]
52. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production.
Fintelman-Rodrigues N; Sacramento CQ; Ribeiro Lima C; Souza da Silva F; Ferreira AC; Mattos M; de Freitas CS; Cardoso Soares V; da Silva Gomes Dias S; Temerozo JR; Miranda MD; Matos AR; Bozza FA; Carels N; Alves CR; Siqueira MM; Bozza PT; Souza TML
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32759267
[TBL] [Abstract][Full Text] [Related]
53. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature.
Gatechompol S; Avihingsanon A; Putcharoen O; Ruxrungtham K; Kuritzkes DR
AIDS Res Ther; 2021 May; 18(1):28. PubMed ID: 33952300
[TBL] [Abstract][Full Text] [Related]
54. Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
Jao J; Yu W; Patel K; Miller TL; Karalius B; Geffner ME; DiMeglio LA; Mirza A; Chen JS; Silio M; McFarland EJ; Van Dyke RB; Jacobson D;
HIV Med; 2018 Mar; 19(3):175-183. PubMed ID: 29159965
[TBL] [Abstract][Full Text] [Related]
55. Detection of SARS-CoV-2 RNA in a conjunctival swab sample in real-time-polymerase chain reaction positive COVID-19 patients and its association with comorbidity and severity at a designated COVID-19 hospital in Central India.
Chawhan A; Athale A; Khan K; Agarwal S; Paul R; Iyer K; Khadia A; Som V
Indian J Ophthalmol; 2021 Dec; 69(12):3633-3636. PubMed ID: 34827010
[TBL] [Abstract][Full Text] [Related]
56. Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients.
Focà E; Calcagno A; Bonito A; Simiele M; Domenighini E; D'Avolio A; Quiros Roldan E; Trentini L; Casari S; Di Perri G; Castelli F; Bonora S
J Antimicrob Chemother; 2017 Nov; 72(11):3163-3166. PubMed ID: 28961777
[TBL] [Abstract][Full Text] [Related]
57. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.
Brown TT; Moser C; Currier JS; Ribaudo HJ; Rothenberg J; Kelesidis T; Yang O; Dubé MP; Murphy RL; Stein JH; McComsey GA
J Infect Dis; 2015 Oct; 212(8):1241-9. PubMed ID: 25948863
[TBL] [Abstract][Full Text] [Related]
58. A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19.
Dou C; Xie X; Peng Z; Tang H; Jiang Z; Zhong Z; Tang J
Diabetes Res Clin Pract; 2020 Aug; 166():108300. PubMed ID: 32663490
[TBL] [Abstract][Full Text] [Related]
59. Treatment durability, effectiveness, and safety with atazanavir/ritonavir-based HAART regimen in treatment-naïve HIV-infected patients.
Tremblay C; Trottier B; Rachlis A; Baril JG; Loutfy M; Lalonde R; Sampalis JS; Boulerice F
HIV Clin Trials; 2011; 12(3):151-60. PubMed ID: 21684855
[TBL] [Abstract][Full Text] [Related]
60. Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results.
Murphy RL; Sanne I; Cahn P; Phanuphak P; Percival L; Kelleher T; Giordano M
AIDS; 2003 Dec; 17(18):2603-14. PubMed ID: 14685054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
